|
|
Media partners 
We work with leading magazines and publishers in this arena. If you are interested in becoming a media partner for this event please contact:
Eileen Hor, Marketing Manager
Email: eileen.hor@terrapinn.com
Tel: (65) 6322 2320
Fax: (65) 6271 2035
|
World Scientific Publishing publishes Asia Pacific Biotech News (APBN), the first and only fortnightly report on pharmaceutical, medical, agricultural and environmental sciences in Asia Pacific. APBN is a premium magazine providing industry professionals and experts with breaking news and updates on biotechnology in Asia Pacific. With its rich contents accompanied by insightful and in-depth reports, APBN is widely read by professionals and researchers in the biotechnology sector around the world. Our magazine has a wide reach to the life sciences and biotech community and is present in major conferences in the region. Please visit http://www.asiabiotech.com
BioPharmaLife-India, the International publication is brought out as a bi-monthly to route the BIOTECH & PHARMA OUTSOURCING activities to India from US and Europe
BioPharmaLife contains up-to-date information on current outsourcing trends in areas of Drug Discovery, Development, Decease Research, Contract Research and manufacturing, Clinical Research, Clinical Trials, BioInformatics and related technology updates covering India, USA, Europe and Asia pacific regions, catering to both the buyers and service providers of Biotech and Pharma outsourcing. It includes in-depth articles, features, interviews, write-ups and extensive coverage of International Biotech & Pharma outsourcing conferences / exhibitions held worldwide.
Issue Highlights include Clinical Trials & Clinical Research market trends, Outsourcing Pharma R & D and manufacturing, Global Healthcare biotech opportunities, The Billion $$$ business of Drug Discovery and lots of Case studies
Cybermedia is South Asia’s Largest Speciality media House with 11 Publications in the Information Technology , Telecom, consumer Electronics,Biotech and Lifesciences Area ; and the media value chain including the internet , events and Television.The group’s Media Services include Market Research (IDC India) , Job Board (Cybermedia Dice),content outsourcing , multimedia, and media education.
BioSpectrum Asia which is the most authoritative and influential source of information of life sciences industry in AsiaPacific Region is published and Distributed by Cybermedia Group. It is uniquely positioned as a specialized business to business information platform for life sciences industry .
Bio Spectrum Asia Provides comprehensive coverage and useful insights in the exciting areas of Pharmaceuticals, Bio Technology, Medical devices, Research and Development and Policies.
BiospectrumAsia is available in three formats :
Print Magazine
Digital Magazine
Daily update newsletter .
Log on to www.biospectrumasia.com to subscribe the magazine free
The vaccine field has been transformed by the technological advances of the past decade. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies. This journal aims to provide the key information needed by decision makers in the development and application of vaccines – from concept to the clinic.
“Expert Review of Vaccines provides an important and unique perspective on the key issues facing vaccinology in the 21st century.”
Andrew J Pollard, University of Oxford, UK
For more information go to www.future-drugs.com or email info@future-drugs.com
Now in its 26th year, GEN retains its position as the most widely read biotechnology publication around the globe. GEN's international purview includes applied research through commercialization. Editorial content includes regulatory, strategic alliances and collaborations, clinical trials, corporate profiles, in-depth interviews with leaders in industry, academia, and government, instructive tutorials in drug discovery and bioprocessing to enhance research results, and new products that enable significant advances in bioscience R&D.
Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, was introduced in 1981, as the first biotechnology trade publication. GEN is now the most widely read bionews publication worldwide.
GEN's unique news editorial mandate is the entirety of the bioproduct life cycle, from early-stage R&D, to applied research and bioprocess, through to commercialization, including marketing and regulatory. GEN is the only publication with this mandate, covering the entirety of commercial bioscience: biopharmaceuticals, bio-agriculture, chemicals and enzymes, and environmental markets, and emerging biosciences including biodefense, bioenergy, and nanobiotechnology. GEN has from the beginning fused industry, academia and government, to foster industry collaborations and agreements.
HPV Today is a newsletter which objective is to convey research information to clinicians and offer a comprehensive view of this rapidly evolving field. HPV Today informs on relevant advances in diagnosis, prevention and clinical management of patients as well as conveying the current thinking of the opinion leaders in the field.
HPV Today currently prints close to 20.000 copies in English and 8.000 in Spanish. Inserts are occasionally published in German, French or Italian. Electronic distribution of HPV Today through scientific societies or individual subscriptions accounts for over 25.000 copies.
PharmaAsia is the leading source of information for scientists in Asia looking to stay abreast of innovative technologies and trends impacting the pharmaceutical industry. Launched in January 2006, the publication provides timely and useful insights into cutting-edge techniques and practices for improving the pace of pharmaceutical research and development in the region. It features in-depth articles on technologies and research relevant to the industry, news and market trends, new product offerings, listings of regional events and profiles of relevant companies and service providers.
PharmaAsia is published bi-monthly in English and sent to 10,000* qualified readers. For more information, please visit our website at www.PharmaAsia.com.
|
|
|
|
